Covered recipient · General Payments record
CHINASA PAUL ANUGWOM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,098.43
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $496.20 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $153.63 | 3 |
| Lilly USA, LLC | $151.14 | 3 |
| ABBVIE INC. | $148.43 | 8 |
| Currax Pharmaceuticals LLC | $16.35 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.37 | 1 |
| DEXCOM, INC. | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.85 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232285 | CMS |
| ABBVIE INC. | $11.57 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232287 | CMS |
| ABBVIE INC. | $13.96 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232289 | CMS |
| ABBVIE INC. | $18.35 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232291 | CMS |
| ABBVIE INC. | $3.11 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232293 | CMS |
| ABBVIE INC. | $32.64 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232295 | CMS |
| ABBVIE INC. | $18.80 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232297 | CMS |
| ABBVIE INC. | $30.15 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232299 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.78 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104343364 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105516743 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.40 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104310404 | CMS |
| Currax Pharmaceuticals LLC | $16.35 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509816 | CMS |
| Dexcom, Inc. | $13.28 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291537 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.37 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146757678 | CMS |
| Lilly USA, LLC | $18.87 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136099602 | CMS |
| Lilly USA, LLC | $119.74 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136093885 | CMS |
| Lilly USA, LLC | $12.53 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136097764 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.